This website uses cookies to enhance the user experience.
||
N

NORGENOTECH AS897 365 812

Limited company
Ullernchausséen 64 0379 OSLO, Norge

NORGENOTECH AS

Operating
NorgenoTech | |
Utvikle og kommersialisere innovative metoder innen bioteknologi, samt annet som står i forbindelse med dette. Videre er formålet å investere i selskap som driver innen samme næring. Slike investeringer skal godkjennes av selskapets generalforsamling med 2/3 (to-tredjedelers) flertall.
Forskning og utviklingsarbeid innen bioteknologi.

Links

Organization

Chairman of the board
Years since formation
15 years
since Sep 20, 2011
Type
Limited company
VAT registered
Yes
Number of employees
5

Ownership

Number of shares and share classes
127,000
1 share class
Total number of shareholders
6
persons
Belongs to group of

Financials

Total operating income 2025
2,655,397
NOK
Annual total result 2025
-62,805
NOK
Total equity 2025
229,099
NOK
Last update: May 19, 2026

Management

Board

NameRoleShares
Chairman
4.13 %
directly
Board Member-
Board Member
10.43 %
directly
Board Member
25.39 %
directly

Others

NameRoleShares
R
REGNSKAPPLUSS AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
49.61 %
directly
Board Member
25.39 %
directly
Board Member
10.43 %
directly
-
7.09 %
directly
Chairman
4.13 %
directly
-
3.35 %
directly
Last update: Dec 16, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
63,000
49.61 %
Ordinary shares
32,250
25.39 %
Ordinary shares
13,250
10.43 %
Ordinary shares
9,000
7.09 %
Ordinary shares
5,250
4.13 %
Ordinary shares
4,250
3.35 %

Shares owned by the NORGENOTECH AS

NameShare classTotal number of sharesShare
C
COMET BIOTECH AS
Ordinary shares
100,000
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2025: NOK 2,655,397
    Operating profit 2025: NOK 31,195
    Employees: 5

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
2,655,397
721,579
3,266,959
3,538,415
3,759,824
Annual Total Result
-62,805
-208,240
473,619
-246,617
17,570
Total assets
2,820,469
811,031
1,262,848
1,271,181
1,934,344
Total liabilities
2,591,370
519,128
762,704
1,244,656
1,661,203
Total equity
229,099
291,904
500,143
26,525
273,141

P&L

Year20252024202320222021
Total operating income
2,655,397
721,579
3,266,959
3,538,415
3,759,824
Total operating costs
2,624,203
969,820
2,601,741
3,831,056
3,710,742
Operating result
31,195
-248,241
665,218
-292,641
49,082
Financial income/costs
-25,423
-9,834
-56,070
-20,890
-27,606
Profit before tax
5,772
-258,075
609,148
-313,532
21,476
Total tax & extraordinary income/cost
68,577
-49,835
135,529
-66,915
3,906
Annual Total Result
-62,805
-208,240
473,619
-246,617
17,570

Balance overview

Year20252024202320222021
Total fixed assets
179,723
251,661
205,389
355,982
317,857
Total current assets
2,640,746
559,370
1,057,459
915,198
1,616,487
Total assets
2,820,469
811,031
1,262,848
1,271,181
1,934,344
Short term debt
2,591,370
519,128
762,704
1,244,656
1,661,203
Long term debt
0
0
0
0
0
Total liabilities
2,591,370
519,128
762,704
1,244,656
1,661,203
Contributed capital
136,680
136,680
136,680
136,680
136,680
Retained earnings
92,419
155,224
363,463
-110,155
136,461
Total equity
229,099
291,904
500,143
26,525
273,141
Total equity and liabilities
2,820,469
811,031
1,262,848
1,271,181
1,934,344

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises